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Objectives. We estimated the burden of disease in the United States attributa-
ble to obesity by gender, with life expectancy, quality-adjusted life expectancy, years
of life lost annually, and quality-adjusted life years lost annually as outcome measures.
Methods. We obtained burden of disease estimates for adults falling into the fol-
lowing body-mass index categories: normal weight (23 to <25), overweight (25 to <30),
and obese (≥30). We analyzed the 2000 Medical Expenditure Panel Survey to obtain
health-related quality-of-life scores and the 1990–1992 National Health Interview Sur-
vey linked to National Death Index data through the end of 1995 for mortality.
Results. Overweight men and women lost 270 000 and 1.8 million quality-
adjusted life years, respectively, relative to their normal-weight counterparts.
Obese men and women lost 1.9 million and 3.4 million quality-adjusted life years,
respectively, per year. Much of the burden of disease among overweight and
obese women arose from lower health-related quality of life and late life mortality.
Conclusions. Relative to men, women suffer a disproportionate burden of dis-
ease attributable to overweight and obesity, mostly because of differences in
health-related quality of life. (Am J Public Health. 2006;96:1662–1668. doi:10.2105/
AJPH.2005.068874)
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Between 1990 and 2000, the age-adjusted
prevalence of obesity increased from 22.9%
to 30.5% and the age-adjusted prevalence of
overweight increased from 55.9% to 64.5%.1
If similar trends continue, obesity may result
in a decline in life expectancy in the United
States.2 This mortality risk arises from a
higher risk of numerous comorbidities, includ-
ing type 2 diabetes, hypertension, hypercho-
lesterolemia, osteoarthritis, gallbladder dis-
ease, and some cancers.3 However, obesity
may also produce psychological morbidity,
especially among women.4
A number of studies have examined the
burden of disease attributable to obesity and
overweight with measures of mortality, such
as annual years of life lost.5 Although mortal-
ity data provide a common comparable end-
point for all diseases, they provide little infor-
mation about the suffering caused by diseases
while people are alive. Morbidity studies typi-
cally capture the association between obesity
and a subset of conditions with which it is as-
sociated.6–11 For instance, the burden of dis-
ease has been measured with the prevalence
of high blood pressure, heart disease, and
other conditions thought to be associated
with obesity.9 However, analyses based on
attributable risk typically exclude diseases
with a psychological dimension and those
that are less prevalent.4
To provide a more comprehensive assess-
ment of morbidity, recent analyses have been
conducted using preference-based health-
related quality-of-life (HRQL) measures of
overweight and obese people.12–14 The advan-
tage of preference-based measures over other
quality-of-life measures is that they can be
used to calculate quality-adjusted life years
(QALYs).15 The recent inclusion of an HRQL
measure (the EuroQoL [EQ-5D]) into a large
national survey makes it possible to capture
the health states of people in the United
States and convert them into QALYs.
We examined the burden of disease in
the US adult general population by body
mass index (BMI). Specifically, we examined:
(1) the distribution of sociodemographic vari-
ables and selected chronic conditions; (2) the
distribution of average HRQL scores by socio-
demographic variables and conditions; (3) the
annual number of deaths, years of life lost to
death, and QALYs in men and women; and
(4) life expectancy and quality-adjusted life
expectancy for men and women.
METHODS
Overview and Definitions
We calculated BMI from self-reported
height and weight. Persons with a BMI of less
than 23 kg/m2 were excluded to avoid con-
founding by underlying medical conditions
unrelated to body weight.16,17 Although the
ideal comparison group has not been defined,
we chose the group with the lowest morbidity
and mortality to form a “normal-weight”
comparator. The use of the group with the
lowest morbidity and mortality maximizes
the burden of disease estimated with national
datasets, but does not completely eliminate
confounding by diseases and conditions unre-
lated to overweight and obesity. We used the
following definitions: BMI 23 to <25 kg/m2=
normal weight; BMI 25 to <30 kg/m2 =over-
weight; BMI ≥30 kg/m2 =obese.
Datasets
We obtained HRQL values from the
Household Component of the 2000 Medical
Expenditure Panel Survey (MEPS), and mor-
tality ratios from the 1990–1992 National
Health Interview Surveys (NHIS) linked to
the National Death Index through the end of
1995.18–20 Both the MEPS and the NHIS are
nationally representative samples of the civil-
ian noninstitutionalized population.
The MEPS includes approximately 25000
persons.18 Although 15438 adults provided
questionnaire data for the EQ-5D, 12% were
proxy responders and were excluded. Also
excluded from our sample were adults with
missing height or weight information (4.3%
of the sample). These persons had slightly
lower self-rated health than those with BMI
information, but were otherwise similar so-
ciodemographically. The final sample con-
sisted of 13646 subjects. All EQ-5D scores
were generated with recently published US
preference weights.21 The EQ-5D self-classifier
included in the MEPS enables the respondent
to categorize his/her health according to 3
levels (no problem, moderate, severe) for 5
dimensions of health.22
The 1990–1992 NHIS included similar
sociodemographic, height, and weight variables
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to those in MEPS.19 The NHIS can be linked
to the National Death Index through the end
of 1995, allowing for prospective mortality
analyses of subjects in the original sample.
The sample included 256900 persons
whose vital statuses were obtained during
the 6 years of follow-up, over which time
11214 persons died. We eliminated the sub-
jects missing height or weight information
(11.7% of the sample); these persons were
older and tended to have higher mortality
(6% vs 4% died) than those with complete
BMI information. After also excluding per-
sons aged younger than 18 years and those
with a BMI<23, 84375 subjects remained
in the analysis.
Calculations
Analyses were conducted using SAS ver-
sion 8.2 (SAS Institute Inc, Gary, NC) and
SUDAAN version 8.0.1 (Research Triangle
Institute, Research Triangle Park, NC). These
statistical packages permit adjustment for the
complex sampling design used in the MEPS
and NHIS. Both MEPS and NHIS data incor-
porated sampling weights and poststratifica-
tion weights.
Spline regressions were employed to derive
smoothed age-specific EQ-5D scores for per-
sons aged 18 years and older.23 Spline regres-
sions correct for bias, particularly at bound-
ary regions, when independent variables are
skewed or have outliers. We generated
HRQL values for persons aged younger than
25 years, 25 to 44 years, 45 to 64 years, 65
to 74 years, and 75 years and older.
Cox proportional hazard survival models
were used to generate the hazard ratios for
overweight and obese relative to normal-
weight individuals. Hazard ratios were gener-
ated from NHIS for the same intervals used
to generate HRQL scores. Each analysis was
adjusted for age and age squared.
Abridged life tables were generated for the
general US population for the year 2000
with age intervals of 5 years (or fewer) to age
90 and older, and mortality data obtained
from the National Center for Health Statis-
tics.24 We calculated quality-adjusted life
expectancy for each subgroup by first gener-
ating reference abridged life tables for nor-
mal-weight persons of each gender and
then by multiplying age- and gender-specific
mortality probabilities in the table by age-
specific HRQL scores. Further details pertain-
ing to the general construction of our life
tables have been published elsewhere.25,26
Overweight- and obesity-related deaths
were calculated as:
(1)
where M=the total number of deaths in age
interval x, e=the proportion of M excess
deaths because of overweight and obesity in
age interval x, and p=the proportion over-
weight or obese in age interval x. Total deaths
were obtained from death certificate data.24
In 2000, there were 2403351 deaths, of
which 356 (0.01%) were excluded because
no information on subjects’ ages was avail-
able. The derivation of this formula is avail-
able from the corresponding author.
Total years of life lost were calculated as:
(2)
where x=the age interval (<25, 25–44,
45–64, 65–74, and ≥75 years), DX is the
number of weight-related deaths within age
interval x, and LX is the life expectancy for
persons above the 2 thresholds at the mid-
point of age interval x. LX was obtained from
life table values for the reference group (e.g.,
23.0 kg/m2≤BMI<25) to reflect the full po-
tential life lost.
The QALYs lost to morbidity were calcu-
lated as:
(3)
where HAx is the HRQL score for normal-
weight persons in age interval x, HBx is the
HRQL score for persons either overweight or
obese in age interval x, and Px is the popula-
tion that is either overweight or obese in age
interval x.
Total QALYs (because of both morbidity
and mortality) were calculated as:
(4)
where QMx is the total number of QALYs be-
cause of morbidity in age interval x, Hx is





























the HRQL score for persons in the BMI
category of interest in age interval x, and Yx
is the number of years of life lost in age
interval x.
RESULTS
Table 1 highlights the sociodemographic
and clinical profile of adults in the MEPS
sample according to the 3 categories of BMI.
Although there were more overweight men
(57%) than women (43%), there were more
obese women (54%) than men (46%). Adults
who were obese compared with normal-
weight persons were more likely to report fair
or poor health, having diabetes, and having
hypertension. All comparisons across rows
are statistically significant at P<.05.
We found that HRQL scores declined with
increasing category of weight with a few nota-
ble exceptions (data not shown). In particular,
overweight non-Hispanic African Americans
and overweight Hispanics had scores that
were similar to the scores of normal-weight
non-Hispanic African Americans and Hispan-
ics. Overweight men had scores that were
similar to the scores of normal-weight men.
Table 2 presents weight-related deaths,
years of life lost, QALYs because of morbid-
ity, and overall QALYs for overweight and
obese persons by age. In the United States,
relative to the normal-weight persons, there
were 15000 additional deaths for overweight
men and 37000 additional deaths for over-
weight women. Similarly, relative to normal-
weight persons, there were 42000 additional
deaths for obese men and 70000 additional
deaths for obese women. Young, overweight
women had fewer deaths than young, over-
weight men.
Overweight men in the United States had
47000 additional years of life lost annually
whereas overweight women had 1 million
additional years of life lost annually relative
to normal-weight persons. Obese men had
1.21 million years of life lost to disease annu-
ally whereas obese women had an additional
1.89 million years of life lost to disease annu-
ally relative to normal-weight persons.
In addition to measuring QALYs as a sum-
mary measure capturing both HRQL and
mortality, we examined QALYs attributable to
HRQL decrements alone. Health-related
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TABLE 1—Basic Sociodemographic and Clinical Characteristics of the Total MEPS Sample
of US Adults, by Body Mass Index (BMI) Category
No. (%)
n BMI 23.0 to < 25 BMI 25.0 to < 30 BMI≥30.0
Total sample 10 301 (100) 2174 (16.8) 4798 (35.5) 3329 (23.1)
Age
18–44 5058 (52.3) 1125 (51.9) 2342 (48.7) 1591 (48.4)
45–64 3465 (30.8) 639 (29.5) 1184 (32.7) 1242 (36.7)
≥65 1778 (16.9) 410 (18.6) 872 (18.6) 492 (14.8)
Race/ethnicity
White, non-Hispanic 6266 (74.5) 1417 (75.9) 2951 (74.9) 1898 (70.6)
Black, non-Hispanic 1488 (11.1) 245 (9.6) 617 (11.1) 625 (15.7)
Asian, non-Hispanic 183 (3.0) 70 (4.1) 88 (2.3) 25 (1.2)
AIAN, non-Hispanic 53 (0.6) 8 (0.5) 21 (0.5) 24 (0.9)
Hispanic 2311 (10.5) 434 (10.0) 1121 (11.2) 756 (11.7)
Gender
Male 5099 (47.3) 971 (46.0) 2682 (57.3) 1444 (46.2)
Female 5202 (52.7) 1203 (54.1) 2114 (42.7) 1885 (53.8)
Marital status 
Married 6309 (56.6) 1258 (55.5) 3037 (61.1) 2014 (58.7)
Widowed 757 (7.2) 157 (7.2) 331 (6.9) 269 (7.7)
Divorced 1143 (11.3) 250 (12.2) 522 (11.9) 371 (11.8)
Separated 224 (1.7) 38 (1.3) 103 (1.8) 83 (2.1)
Never married 1868 (23.3) 471 (23.8) 805 (18.3) 592 (19.7)
Insurance
Any private 7237 (74.4) 1556 (75.3) 3471 (76.5) 2210 (71.4)
Public only 1561 (13.5) 327 (14.7) 664 (12.8) 570 (15.0)
Uninsured 1503 (12.1) 291 (10.0) 663 (10.8) 549 (13.6)
Self-reported health/condition 
Fair or poor health 1798 (15.0) 302 (12.3) 731 (13.3) 765 (21.1)
Diabetes 869 (6.3) 86 (3.2) 352 (6.7) 431 (11.6)
Asthma 938 (9.2) 166 (8.3) 403 (9.1) 370 (11.3)
Hypertension 2396 (19.8) 338 (15.2) 1010 (21.1) 1048 (31.2)
Heart disease 1066 (10.2) 204 (9.6) 456 (10.2) 406 (12.5)
Number of conditionsa
0 6580 (67.2) 1561 (72.2) 3192 (66.1) 1827 (55.3)
1 2482 (22.8) 463 (21.0) 1095 (23.2) 924 (28.0)
2 or more 1238 (10.1) 149 (6.8) 571 (10.8) 578 (16.8)
Note. MEPS = 2000 Medical Expenditure Panel Survey; AIAN = American Indian/Alaska Native. Column values add to 100% for
each sociodemographic category. Subgroup comparisons all differ at P < .05; larger differences are highlighted in the text.
a Total number of self-reported medical conditions.
quality-of-life decrements because of being
overweight were nearly 4 times higher among
women than among men (960000 QALYs
and 243000 QALYs, respectively). Differ-
ences in HRQL among obese women were
slightly greater than 2 times higher than
among obese men (1.95 million QALYs and
912000 QALYs, respectively).
Overweight women had a 6.6-times higher
burden of disease in total QALYs relative to
overweight men (1.78 million QALYs relative
to 270000 QALYs). The burden of disease
among obese women was 1.8 times higher
than among obese men (3.4 million QALYs
relative to 1.94 million QALYs).
Figure 1 shows the total years of life and
QALYs lost to overweight and obesity by gen-
der per 100000 persons. Here, we see that
the rate (per 100000 persons) of QALYs lost
to morbidity for obese and overweight men
remained relatively steady by age, whereas
years of life lost by men generally increased
with age. For both obese and overweight
women, the rate of years of life lost was
lower than the rate of QALYs lost to morbid-
ity at young ages and then crossed around
age 35 to 45 years before converging again
later in life.
Table 3 shows the lifetime burden of disease
for the 3 categories of BMI examined. Men
aged 18 years in the normal-weight category
had a life expectancy roughly equal to men of
the same age in the overweight category—both
57 years. Obese men had a life expectancy of
54.3 years. By contrast, overweight women
had a shorter lifespan than normal-weight
women (62.4 vs 63.5 years). Obese women
had a life expectancy of 60.7 years.
Differences in quality-adjusted life expect-
ancy demonstrated larger differences by gen-
der. Normal-weight men lived 0.5 QALY more
than overweight men, and 4.4 QALYs more
than obese men. Women in the normal-weight
range lived 2.9 QALYs more than overweight
women and 7.2 QALYs more than obese
women. (Differences between these values
and those in Table 3 are because of rounding.)
DISCUSSION
When we looked at data representative
of the US adult household population, we
found that being overweight or obese had a
profound impact on the length and quality
of life, and that the interplay of morbidity
and mortality produced disparate results for
men and women. Being overweight had a
small effect on both HRQL and mortality
among men (270 000 QALYs lost), but a
large impact on both outcomes for women
(1.78 million QALYs lost). Likewise, obesity
had a much greater impact on HRQL and
mortality for obese women relative to obese
men, producing a total of 1.94 million
QALYs lost for men and 3.40 million
QALYs lost for women.
However, this is not true across all age
groups. Obese women aged younger than 45
years appeared to have lower excess mortal-
ity than younger obese men. After age 45,
mortality for obese women far surpassed that
of men (Figure 1). This pattern—a flip in male
versus female mortality at age 45—has been
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TABLE 2—Annual Overweight- and Obesity-Associated Deaths, Years of Life Lost (YLLs), and
Quality-Adjusted Life Years (QALYs) Lost Relative to the Normal-Weight (BMI 23 to <25)
Group, by Age Group and Gender in US Adults
Men Women
Age Group BMI 25 to < 30 BMI≥30 BMI 25 to < 30 BMI≥30
Deathsa
< 25 –290 1463 –29 85
25–44 4673 10 430 –750 3276
45–64 –12 204 12 187 18 587 27 243
65–74 6904 8561 10 952 23 180
≥75 16 028 8910 7982 16 406
Total 15 111 41 550 36 742 70 190
YLLsa
< 25 –18 773 94 850 –2015 5962
25–44 203 101 453 258 –36 145 157 897
45–64 –422 780 422 169 718 620 1 053 277
65–74 120 237 149 093 228 580 483 801
≥75 165 161 91 814 93 298 191 755
Total 46 946 1 211 185 1 002 337 1 892 692
QALYs (morbidity)b
< 25 59 435 84 543 40 573 90 175
25–44 184 175 387 308 332 841 627 899
45–64 39 676 330 701 359 067 769 054
65–74 –17 394 74 246 138 102 274 356
≥75 –23 245 35 545 88 999 185 140
Total 242 647 912 343 959 583 1 946 624
QALYs (total)a,b
< 25 41 774 171 673 38 744 95 440
25–44 370 763 790 373 300 960 761 284
45–64 –329 656 683 947 959 618 1 597 952
65–74 81 452 190 207 319 260 627 206
≥75 105 726 102 488 161 401 317 708
Total 270 059 1 938 689 1 779 983 3 399 590
Note. BMI = body mass index.
aValues were calculated using 2000 vital statistics24 and National Health Interview Survey data linked to the National Death
Index data.19,20
bBased on 2000 Medical Expenditure Panel Survey data.18
observed before.17 This previous study used
merged data from National Health and Nutri-
tion Epidemiological Follow-Up Study and
National Health and Nutrition II Mortality
Study, but did not provide HRQL data to
contextualize it.
Across all ages, HRQL was significantly
lower among obese women than obese men;
women aged younger than 45 years lost 1.5
times as many QALYs to morbidity than did
men in the same age group. There are sev-
eral possible overlapping explanations for
these disparate gender findings. First, mortal-
ity by BMI may be confounded by muscle
mass in very fit men. This hypothesis explains
why overweight men have lower mortality
than overweight women, but does not explain
the distribution of years of life lost by age
seen in Figure 1. Second, obesity in women
may be more strongly associated with mor-
bidity that translates into later mortality than
in men. Third, psychological morbidity associ-
ated with obesity-related stigma might con-
tribute to both the greater HRQL burden in
women than men and the later increase in
mortality in women.
This third hypothesis is consistent with
other authors’ findings that there was a much
stronger association between depression and
BMI in women than in men.4,27 It is also con-
sistent with our finding that obese and over-
weight women of all ages suffered dispropor-
tionately from lower HRQL relative to men.
Stress and depression have been linked to in-
creases in the release of cortisol, vasopressors,
and oxidative chemicals, which in turn may
lead to an increased risk of the metabolic syn-
drome and heart disease—a process that nec-
essarily takes years to lead to increases in
mortality.27–30 Conversely, it is plausible that
stress, anxiety, and depression could be the
cause of obesity and higher mortality in the
first place, or that a 2-way causal relationship
exists.
When we compared the overweight and
obese categories within genders, we found
that men experienced slightly less than a 
3-fold increase in the number of excess
deaths when moving from the overweight to
the obese category and a 7-fold increase in
QALYs lost. Women, on the other hand, expe-
rienced less than a 2-fold increase in deaths
and QALYs when moving between these
categories. It is possible that men catch up to
women in total QALYs lost in the obese cate-
gory because of the aforementioned physio-
logical differences in body fat versus lean
muscle mass distribution by gender. Alterna-
tively, this might happen once BMI is high
enough to affect labor market participation
among men (thus affecting access to health
insurance or other goods and services that
might affect survival). Clearly, more research
is needed to iron out the pieces of these dif-
ferences in quality versus quantity of life by
age and gender.
Whereas these annual losses are indicative
of the burden of disease to society as a
whole, changes in life expectancy and quality-
adjusted life expectancy provide information
on the burden of disease among individuals
(Table 3). We found that being overweight
had a modest impact on male quality-adjusted
life expectancy: +0.5 QALY relative to nor-
mal-weight men. However, overweight had a
relatively large impact on female quality-
adjusted life expectancy: –2.9 fewer QALYs
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Note. The measure of morbidity is the health-related quality of life (HRQL) score translated in QALYs lost to morbidity alone.
FIGURE 1—Total years of life lost and quality-adjusted life years (QALYs) lost to overweight
and obesity by gender per 100000 persons for overweight males (a), overweight females
(b), obese males (c), and obese females (d). (Continued)
over a lifespan. Being obese had a large im-
pact on quality-adjusted life expectancy for
both sexes: –4 QALYs for men and –7
QALYs for women. Although no other au-
thors have examined quality-adjusted life ex-
pectancy by BMI, other authors have exam-
ined differences in unadjusted life expectancy
by BMI.2,31 These authors predict that, if
trends continue, life expectancy in the United
States will ultimately fall because of high rates
of obesity among youngsters.
Likewise, although we did not conduct a
trend analysis, it is conceivable that such
trends will erase the gender gap in life expect-
ancy. Were all women within the normal-
weight category (BMI 23 to <25), life expect-
ancy for women would be 1.8 years longer
and 3.9 QALYs longer than it is now.24 For
men, there would be little change in life ex-
pectancy, and just 0.7 QALYs would be added
to male quality-adjusted life expectancy.
There are, as of yet, few burden-of-disease
analyses that also include quality-adjusted life
expectancy or QALYs lost annually as out-
come measures from which comparisons can
be made to overweight and obesity. One ex-
ception is a recent study of poverty.32 Because
the prevalence of obesity is higher than that of
poverty, more QALYs are lost to obesity (5.3
million) every year than to poverty (3.1 mil-
lion). However, the impact of obesity on qual-
ity-adjusted life expectancy is considerably
lower than that for poverty. Whereas obese
18-year-olds in the general US population
have approximately 47 QALYs ahead of them,
those 18-year-olds living under the poverty
threshold can expect to live just 43 QALYs.
That obesity has a large impact on QALYs lost
annually in the population, but a relatively
smaller impact on QALYs lost among the aver-
age obese person underscores the fact that the
burden of disease because of obesity is driven
more by its high prevalence than its severity.
Flegal et al. recently released revised esti-
mates of annual deaths because of overweight
and obesity.5 They used subjects in the BMI
from 18.5 to less-than-25 range as a compari-
son group rather than the BMI from 23 to
less-than-25 group we employed. Inclusion of
persons with a BMI less than 23 produces a
comparison group that is less healthy than the
BMI from 23 to less-than-25 group.17 This
less-healthy reference group may therefore
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TABLE 3—Years of Perfect Health, Life Expectancy, and Quality-Adjusted Life Expectancy
Among US Adults, by Body Mass Index
Men Women
Body mass index 23 to < 25 25 to < 30 ≥30 23 to < 25 25 to < 30 ≥30
Life expectancy at birth 74.1 73.8 71.5 80.8 79.6 78
Life expectancy at age 18 y 57 56.7 54.3 63.5 62.4 60.7
Quality-adjusted life 50.5 50 46.1 55.6 52.7 48.4
expectancy at age 18 y
Note. BMIs were based on National Health Interview Survey–National Death Index data19,20 and 2000 life tables obtained
from the National Center for Health Statistics.24
result in an underestimate of the burden of
disease attributable to overweight and obesity.
If so, the use of this reference group partly ac-
counts for their finding that overweight per-
sons are at lower risk of mortality than nor-
mal-weight persons.5,33 Subjects within any
BMI group will have morbidity unrelated to
their body weight. Nonetheless, we felt that the
group with the lowest morbidity and mortality
serves as the optimal “normal” comparison
group and therefore provides a more accurate
picture of the relationship between being over-
weight or obese and health outcomes.
Our study had a number of limitations. First,
subanalyses by gender and age resulted in a
good deal of random error in our parameter es-
timates. At the outset of this analysis, we de-
cided to produce estimates that minimized non-
random error. We thus used age-specific hazard
ratios (rather than age-adjusted hazard ratios)
and derived EQ-5D scores using spline regres-
sion. Though the use of age-specific hazard ra-
tios and HRQL scores increased random error
in the analysis, the use of age-adjusted
summary values would have introduced
non–random error.34 The use of age-specific
estimates for both HRQL and mortality made
the derivation of 95% confidence intervals
around our summary outcome indicators com-
putationally prohibitive. Our findings, however,
were largely consistent with other estimates of
HRQL and mortality.13,17
Second, we calculated age-specific risk ra-
tios for mortality using mortality data from
1990 through 1995; newer data were not
readily available via public access. There is ev-
idence that BMI is increasing among persons
already categorized as obese.33 Therefore, it is
possible that our hazards ratios underestimate
the burden of disease today.
Third, we assumed that all excess mortality
by BMI is attributable to obesity. However,
differences may have existed among the
groups because of other sociodemographic
factors that may have affected the results.
Fourth, height and weight were self-
reported. Obese persons have been found
to be more likely to underestimate their
weights and heights than are nonobese per-
sons, women may be more likely to underesti-
mate their weight, and men may be more
likely to overestimate their heights.35,36 Thus,
the actual number of overweight and obese
persons may be higher.
Fifth, because of the limited number of re-
sponse categories in the EQ-5D for each ques-
tion, a ceiling effect may occur when measur-
ing the health status of the US general
population, which may limit its sensitivity to
mild morbidity effects. Sixth, we eliminated
proxy responders to the EQ-5D. Proxy respon-
ders tended to be poorer, less educated, and
more likely to be African American or His-
panic. Finally, we omitted those with missing
height and weight information. While 4.3% of
persons were omitted from the HRQL analysis,
11.7% of subjects were omitted from the mor-
tality analysis. These subjects tended to be
older and have higher mortality than those for
whom height and weight were available.
In conclusion, with MEPS and NHIS data,
we examined the burden of disease in the
United States because of overweight and obe-
sity separately for men and women. We
found that the inclusion of morbidity greatly
changed what we know about the distribution
of the burden of disease attributable to obe-
sity by gender. Further research is needed to
elucidate the factors that drive the gender dif-
ferences in morbidity and mortality. It is pos-
sible that the obesity epidemic will not only
shape the overall mortality experience in the
future, but also will affect differences in the
total burden of disease by gender.
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